FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/12/060649 [Registered on: 21/12/2023] Trial Registered Prospectively
Last Modified On: 27/04/2026
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Nutraceutical 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Regular eating of betel leaves beneficial in heart patients 
Scientific Title of Study
Modification(s)  
Cardioprotective Effects of Piper Betle in Heart Failure with Reduced Ejection Fraction: A Clinical Study  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Swati Khartode 
Designation  Chief Dietitian 
Affiliation  Vishwaraj Hospital 
Address  OPD No-7, Ground floor, Vishwaraj Hospital, Near Loni Station, Pune- solapur highway, next to hadapsar, Loni , 412210

Pune
MAHARASHTRA
412210
India 
Phone  9767133699  
Fax    
Email  opd@vrhpune.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Swati Khartode 
Designation  Chief Dietitian 
Affiliation  Vishwaraj Hospital 
Address  OPD No-7, Ground floor, Vishwaraj Hospital, Near Loni Station, Pune- solapur highway, next to hadapsar, Loni , 412210


MAHARASHTRA
412210
India 
Phone  9767133699  
Fax    
Email  opd@vrhpune.com  
 
Details of Contact Person
Public Query
 
Name  Dr Swati Khartode 
Designation  Chief Dietitian 
Affiliation  Vishwaraj Hospital 
Address  OPD No-7, Ground floor, Vishwaraj Hospital, Near Loni Station, Pune- solapur highway, next to hadapsar, Loni , 412210


MAHARASHTRA
412210
India 
Phone  9767133699  
Fax    
Email  opd@vrhpune.com  
 
Source of Monetary or Material Support  
Vishwaraj Hospital 
 
Primary Sponsor  
Name  Vishwaraj Hospital 
Address  Vishwaraj Hospital, Near Loni Station, Pune- solapur highway, next to hadapsar, Loni, 412210  
Type of Sponsor  Private hospital/clinic 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Swati Khartode  Vishwaraj Hospital  Near Loni Station, Pune- solapur highway, next to hadapsar, Loni, 412210
Pune
MAHARASHTRA 
9767133699

opd@vrhpune.com 
 
Details of Ethics Committee
Modification(s)  
No of Ethics Committees= 3  
Name of Committee  Approval Status 
Institutional Ethics Committee MAEER’s Vishwaraj Hospital Ethics Committee  Approved 
MAEERS Vishwaraj Hospital   Approved 
MAEERS Vishwaraj Hospital  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: I509||Heart failure, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Fresh Betel Leaves  Fresh Betel leaves Dose:- 3-4 fresh betel leaves (10-15 gms leaves) Duration- 2 months 
Comparator Agent  NA  NA 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  Confirmed diagnosis of low ejection fraction by 2 D Echo report, male and female patients of 18-65 years age group. 
 
ExclusionCriteria 
Details  1. Chronic Kidney disease (CKD)
2. Intestinal mal absorption disorders like colitis, IBS etc 
 
Method of Generating Random Sequence   Other 
Method of Concealment   Other 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Improvement in ejection fraction by 2 D Echo  2 months 
 
Secondary Outcome  
Outcome  TimePoints 
Improvement in symptoms occurred due to low ejection fraction  2 months 
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "102"
Final Enrollment numbers achieved (India)="102" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   29/12/2023 
Date of Study Completion (India) 21/04/2025 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

 

STUDY

RATIONALE

Background and Purpose of the study:

Heart failure (HF) is a global public health problem that affects more than 26 million people worldwide. The global burden of heart failure is growing and is expected to increase substantially with the ageing of the population. Heart failure with reduced ejection fraction accounts for approximately 50% of all cases of heart failure in the United States and is associated with significant morbidity and reduced quality of life. Diseases like myocardial infarction, certain infectious diseases and endocrine disorders, can initiate a primary pathophysiological process that can lead to reduced ventricular function and to heart failure (Bloom, et al. 2017). The management of HF with reduced ejection fraction has seen significant scientific breakthrough in recent decades, and the ability to alter the natural history of the disease has never been better. Disease morbidity and mortality remain high, with a 5-year survival rate of 25% after hospitalization for HF with reduced ejection fraction (Murphy, S. P., Ibrahim, N. E., & Januzzi, J. L. (2020). Heart failure is a progressive condition. Approximately one-half of HF patients have heart failure with reduced ejection fraction (HFrEF). In the real-world setting, 1 in 6 patients with HFrEF develop worsening HF within 18 months of HF diagnosis. These patients have a high risk for 2-year mortality and recurrent HF hospitalizations. The use of standard-of-care therapies both before and after the onset of worsening HF is low. With high unmet medical need, patients with worsening HF require novel treatment strategies as well as greater optimization of existing guideline-directed therapy.

 

Importance of Nutrition in Heart Failure: Implementation of evidence-based nutrition strategies which have shown benefit in carefully controlled clinical trials may positively impact HF outcomes in a cross section of the HF population. Use of the DASH (Dietary Approach to Stop Hypertension) diet in diagnosed HF patients has not yet become standard of care in HF management as it has not been evaluated in pragmatic clinical trials. Many research studies evaluating the effectiveness and implementation of the DASH diet for outpatient HF management are acceptable and have the potential to influence the future health care approaches in CVD prevention, treatment, and management (Wickman, et al. 2021).  The gut microbiota plays a critical role in the pathogenesis of heart failure through complex signaling pathways and interactions. A healthy diet is able to reduce inflammation and promote healthy gut microbiota biodiversity that promotes cardio protective effects and also limits the progression of metabolic, cardiovascular and neurological diseases. Dietary interventions are promising non-pharmacologic therapeutic approaches that patients could benefit from and should be at the core of interventional studies. Future studies need to focus on the clinical application of several therapeutic interventions that have proved to be beneficial so far in order to reduce the prevalence of cardiovascular diseases (Masenga, et al. 2023) 

 

Betel leaves:

The fresh leaves of betel vine are popularly known as ‘Paan’ in India, which are consumed by about 15-20 million people in the country (Guha, P. (2006). Piper betle L., belonging to Piperaceae family, known as a traditional herbal medicinal plant, which are consumed by about 15-20 million people in the country. It is cultivated following the traditional methods in India on about 55,000 ha with an annual production worth about Rs 9000 million and used for several health benefits in Asian countries. Currently, demand for its products such as herbal drugs, medicines, and natural herbal formulations have increased. The beneficial effects of betel leaves and its products have traditionally exploited for the treatment of several diseases like bad breath, cuts, injuries, inflammations, cold cough, indigestion, etc. Till now, a broad range of bioactive compounds including polyphenols, terpenes, etc., has been identified from the extracts and essential oil of betel leaves (Guha, P. (2006), (Madhumita, M., Guha, P., & Nag, A. (2020).

Medicinal uses of betel leaves: Betel leaves have a tremendous potential as a potent source for novel therapeutic usage and has anti-fertility activities, anti-allergic activities, antiulcer property, antioxidant property, anticancer activity and many beneficial properties, these wide pharmacological profile reveals it to be fit for its future usage as a promising source for treating various conditions. Therefore, in the near future the standardization and stabilization studies on the leaf extract can be carried out which can help in improving its usage for varied medicinal usage (Rekha, V. et al. 2014)

Ayurveda Significance:

Piper betel is a Vedic plant and its Vedic name is Saptasira and in sankrit it known as Tambool, Nagvelleri, Nagani were used as remedy against various diseases. In most of these texts were various medicinal properties has been highlighted.  In Ayurveda betel leaf extract is frequently used as an adjuvant and mixed with different medicines possibly for better effects beside its independent use as medicine. In addition to these, the aphrodisiac effect of betel chewing has been indicated in ancient texts. Leaf also believed to provide strength to heart and regulate blood. Its utility as anti-inflammatory and anti-microbial is emphasized at several place. In Ayurveda it acts as vata and kapha suppressant. It also helps in expelling out the mucus from the respiratory tract because of its hot potency. The chewing of betel leaf results cardio-tonic action by accelerating catecholamine from adrenal cortex contributing to increase the stamina of the cardiac muscles, heart rate, blood pressure and sympathetic neural activity. It has also the platelet inhibition activity leads vasorelaxation effect mediated through endothelium dependent and nitric oxide pathways. Hence, betel leaf is beneficial for different cardiovascular disorders like Congestive heart failure, Coronary artery disease, acute myocardial infarction, atherosclerosis etc.  Leaf is considered to provide strength to the heart (cardio tonic) and regulates irregular heart beat and blood pressure (Pradhan, D., et al. (2013).

 

 

       Nutritive Values of 100 gms Betel leaves*

Protein

2.5 gms

Fibre

2 gms

Energy

45 Kcal

Vit K1

210 microgram

Beta-Carotene

4.5 mg

Lutein

5 mg

Potassium

650 mg

Calcium

210 mg

Iron

3 mg

Omega 3 fatty acids

150 mg

Clorogenic acid

6.8 mg

 * Indian Food Composition tables-2017

                                 

 

Thus we have seen that heart failure patients with low ejection fraction can be beneficial from lifestyle modification by dietary changes and exercise, as per Ayurveda betel leaves are useful in improve for cardiac health, so we will be conducted a nutrition intervention by including betel leaves in low ejection fraction cardiac patients to see any improvement in ejection fraction,  as betel leaves are available all over the India throughout the year.   

 

 

 
Close